Erik Kinnman Healthcare News

This is selected healthcare news for Erik Kinnman, which is filed under People. There are 14 news items for this page.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source
1/4/2021 BioStock: Ablivas KL1333 heading for phase II/III in 2021
... received green lights from the FDA and MHRA regarding an accelerated development plan, and it is now working intensively to realize that plan during the year to come. BioStock has spoken to CEO Erik Kinnman to hear his thoughts on what to expect next for Abliva. Read the full article ...
cision.com
2/19/2020 NeuroVive Pharmaceutical AB Year End Report January - December 2019
... NeuroVive's web site www.neurovive.com . The information was submitted for publication, through the agency of the contact person set out below at 08:40 a.m. CET on 19 February 2020 . For more information please contact: Erik Kinnman , CEO +46 (0)46-275-62-20 NeuroVive Pharmaceutical AB (publ) Medicon Village, SE-223 81 Lund, Sweden ...
PR Newswire
12/20/2019 NeuroVive Completes Recruitment in the Second Part of its Ongoing KL1333 Clinical Phase Ia/b Study
... optimize the patient selection criteria and use of endpoints. These are important steps in the opportunity of developing KL1333 towards a life changing treatment for patients with primary mitochondrial disease", said NeuroVive's CEO Erik Kinnman . The information was submitted for publication, through the agency of the contact person set out ...
PR Newswire
12/20/2019 NeuroVive Completes Recruitment in the Second Part of its Ongoing KL1333 Clinical Phase Ia/b Study Yahoo News
12/4/2019 How Much Did NeuroVive Pharmaceutical AB’s (STO:NVP) CEO Pocket Last Year? Yahoo News
11/20/2019 NeuroVive Pharmaceutical AB Interim Report January - September 2019 Financial Times
11/20/2019 NeuroVive Pharmaceutical AB Interim Report January - September 2019 Financial Times
11/20/2019 NeuroVive Pharmaceutical AB Interim Report January - September 2019 PR Newswire
5/10/2019 NeuroVive’s IND for Clinical Development of NeuroSTAT Approved by FDA Business Insider
5/10/2019 NeuroVive’s IND for Clinical Development of NeuroSTAT Approved by FDA Business Insider
5/10/2019 NeuroVive’s IND for Clinical Development of NeuroSTAT Approved by FDA PR Newswire